Kindred Biosciences (NDAQ:KIN) Coveraged By CL King; Uss Investment Management LTD Has Trimmed Its Cae (CAE) Holding

December 28, 2017 - By rebbecca

Among 3 analysts covering Kindred Biosciences (NDAQ:KIN), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Kindred Biosciences has $10.50 highest and $9.50 lowest target. $10’s average target is 4.17% above currents $9.6 stock price. Kindred Biosciences had 3 analyst reports since June 16, 2017 according to SRatingsIntel. The stock of Kindred Biosciences, Inc. (NASDAQ:KIN) earned “Buy” rating by Aegis Capital on Friday, June 16. H.C. Wainwright initiated Kindred Biosciences, Inc. (NASDAQ:KIN) rating on Friday, November 17. H.C. Wainwright has “Buy” rating and $9.50 target. The rating was initiated by CL King on Wednesday, December 27 with “Neutral”.

Uss Investment Management Ltd decreased Cae Inc (CAE) stake by 13.17% reported in 2017Q3 SEC filing. Uss Investment Management Ltd sold 414,010 shares as Cae Inc (CAE)’s stock rose 0.90%. The Uss Investment Management Ltd holds 2.73M shares with $47.94 million value, down from 3.14 million last quarter. Cae Inc now has $5.00B valuation. The stock decreased 0.05% or $0.01 during the last trading session, reaching $18.41. About 137,305 shares traded. CAE Inc. (NYSE:CAE) has risen 26.75% since December 28, 2016 and is uptrending. It has outperformed by 10.05% the S&P500.

Analysts await CAE Inc. (NYSE:CAE) to report earnings on February, 13. They expect $0.22 EPS, up 10.00% or $0.02 from last year’s $0.2 per share. CAE’s profit will be $59.71M for 20.92 P/E if the $0.22 EPS becomes a reality. After $0.17 actual EPS reported by CAE Inc. for the previous quarter, Wall Street now forecasts 29.41% EPS growth.

Uss Investment Management Ltd increased Baidu Inc (NASDAQ:BIDU) stake by 343,500 shares to 562,600 valued at $139.35M in 2017Q3. It also upped Clorox Co Del (NYSE:CLX) stake by 6,600 shares and now owns 53,500 shares. Travelers Companies Inc (NYSE:TRV) was raised too.

Among 9 analysts covering CAE Inc. (NYSE:CAE), 5 have Buy rating, 1 Sell and 3 Hold. Therefore 56% are positive. CAE Inc. has $20 highest and $17 lowest target. $18.33’s average target is -0.43% below currents $18.41 stock price. CAE Inc. had 16 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was downgraded by Zacks on Wednesday, August 26 to “Hold”. The firm has “Outperform” rating by Macquarie Research given on Friday, May 27. The firm has “Outperform” rating by National Bank Canada given on Friday, May 6. Zacks upgraded the shares of CAE in report on Friday, August 14 to “Sell” rating. The rating was downgraded by RBC Capital Markets on Friday, November 11 to “Sector Perform”. The rating was upgraded by IBC to “Outperform” on Monday, January 4. Zacks downgraded the shares of CAE in report on Tuesday, September 1 to “Hold” rating. The rating was upgraded by Desjardins Securities to “Buy” on Thursday, August 13. The stock of CAE Inc. (NYSE:CAE) earned “Sector Perform” rating by IBC on Friday, November 11. The rating was upgraded by BMO Capital Markets to “Outperform” on Friday, February 12.

Investors sentiment increased to 1.29 in Q3 2017. Its up 0.14, from 1.15 in 2017Q2. It improved, as 9 investors sold CAE shares while 47 reduced holdings. 20 funds opened positions while 52 raised stakes. 132.48 million shares or 2.20% less from 135.47 million shares in 2017Q2 were reported. Old Mutual Customised Solutions (Proprietary) Ltd holds 8,557 shares. Cidel Asset Mngmt has invested 0.14% of its portfolio in CAE Inc. (NYSE:CAE). Lpl Fin Limited Liability Company accumulated 0% or 21,122 shares. Pennsylvania-based Glenmede Na has invested 0% in CAE Inc. (NYSE:CAE). Shell Asset Mgmt holds 77,747 shares or 0.02% of its portfolio. Parametric Portfolio Associates has 390,623 shares. Alliancebernstein LP invested in 0% or 22,278 shares. Northern Tru owns 95,611 shares. Manufacturers Life Insurance Communications The, Ontario – Canada-based fund reported 1.86M shares. Renaissance Techs has 1.97M shares. Td Asset Management holds 0.18% of its portfolio in CAE Inc. (NYSE:CAE) for 6.73M shares. Greenleaf Tru holds 0.01% in CAE Inc. (NYSE:CAE) or 13,427 shares. Ameriprise has invested 0% in CAE Inc. (NYSE:CAE). 474,300 were accumulated by Price T Rowe Assocs Md. Moreover, Comerica Bank & Trust has 0% invested in CAE Inc. (NYSE:CAE) for 14,423 shares.

It closed at $9.6 lastly. It is up 71.15% since December 28, 2016 and is uptrending. It has outperformed by 54.45% the S&P500.

Kindred Biosciences, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for pets. The company has market cap of $270.32 million. The companyÂ’s product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. It currently has negative earnings. The Company’s lead product candidates include Zimeta, a dipyrone injection for the control of pyrexia in horses; and Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats.